New Africa variant, page-48

The fact remains @stoway they can say in their marketing that they have done a human trial regardless if it is flawed ….. so can SaNOtize who are running a subsequent trial in guess where - India


https://www.biospace.com/article/re...notize-s-breakthrough-treatment-for-covid-19/


There is some reason the India registration has gone nowhere in 6 months … what could it be ?


SaNOtize also made an application to the MHRA for emergency use in the UK …. could their application in April this year be the hold up for Viraleze in the UK given they have done human trials and we haven’t save and except for the safety trial in Perth ?


It’s about time JF & Co. lost the arrogance and bit the bullet and undertakes a trial for Viraleze; even if they went down the path of treatment for patients after testing positive like was discussed at the AGM…. It would be something to hang their hat on instead of just WHO accepted animal trials and a human ‘safety’ trial … the arrogance and pushback by JF & Co. is IMO why we are where we are in the USA with the FDA Vivagel saga 3+ years later !


A TGA approval or rectification of the UK debacle will restore confidence in Viraleze IMO but it wouldn’t hurt to conduct a human trial in the interim - it’s not like they aren’t cashed up